SwePub
Sök i LIBRIS databas

  Extended search

WFRF:(Nuevo Javier)
 

Search: WFRF:(Nuevo Javier) > (2019) > Prospective observa...

  • 1 of 1
  • Previous record
  • Next record
  •    To hitlist
  • Reddel, Helen K (author)

Prospective observational study in patients with obstructive lung disease : NOVELTY design

  • Article/chapterEnglish2019

Publisher, publication year, extent ...

  • 2019-02-01
  • European Respiratory Society (ERS),2019
  • electronicrdacarrier

Numbers

  • LIBRIS-ID:oai:DiVA.org:uu-400272
  • https://urn.kb.se/resolve?urn=urn:nbn:se:uu:diva-400272URI
  • https://doi.org/10.1183/23120541.00036-2018DOI

Supplementary language notes

  • Language:English
  • Summary in:English

Part of subdatabase

Classification

  • Subject category:ref swepub-contenttype
  • Subject category:art swepub-publicationtype

Notes

  • Asthma and chronic obstructive pulmonary disease (COPD) have overlapping clinical features and share pathobiological mechanisms but are often considered distinct disorders. Prospective, observational studies across asthma, COPD and asthma-COPD overlap are limited. NOVELTY is a global, prospective observational 3-year study enrolling ∼12 000 patients ≥12 years of age from primary and specialist clinical practices in 19 countries (ClinicalTrials.gov identifier: NCT02760329). NOVELTY's primary objectives are to describe patient characteristics, treatment patterns and disease burden over time, and to identify phenotypes and molecular endotypes associated with differential outcomes over time in patients with a diagnosis/suspected diagnosis of asthma and/or COPD. NOVELTY aims to recruit real-world patients, unlike clinical studies with restrictive inclusion/exclusion criteria. Data collected at yearly intervals include clinical assessments, spirometry, biospecimens, patient-reported outcomes (PROs) and healthcare utilisation (HCU). PROs and HCU will also be collected 3-monthly via internet/telephone. Data will be used to identify phenotypes and endotypes associated with different trajectories for symptom burden, clinical progression or remission and HCU. Results may allow patient classification across obstructive lung disease by clinical outcomes and biomarker profile, rather than by conventional diagnostic labels and severity categories. NOVELTY will provide a rich data source on obstructive lung disease, to help improve patient outcomes and aid novel drug development.

Subject headings and genre

Added entries (persons, corporate bodies, meetings, titles ...)

  • Gerhardsson de Verdier, Maria (author)
  • Agustí, Alvar (author)
  • Anderson, Gary (author)
  • Beasley, Richard (author)
  • Bel, Elisabeth H (author)
  • Janson, ChristerUppsala universitet,Lungmedicin och allergologi(Swepub:uu)chrisjn (author)
  • Make, Barry (author)
  • Martin, Richard J (author)
  • Pavord, Ian (author)
  • Price, David (author)
  • Keen, Christina (author)
  • Gardev, Asparuh (author)
  • Rennard, Stephen (author)
  • Sveréus, Alecka (author)
  • Bansal, Aruna T (author)
  • Brannman, Lance (author)
  • Karlsson, Niklas (author)
  • Nuevo, Javier (author)
  • Nyberg, Fredrik (author)
  • Young, Simon S (author)
  • Vestbo, Jørgen (author)
  • Uppsala universitetLungmedicin och allergologi (creator_code:org_t)

Related titles

  • In:ERJ open research: European Respiratory Society (ERS)5:12312-0541

Internet link

Find in a library

To the university's database

  • 1 of 1
  • Previous record
  • Next record
  •    To hitlist

Kungliga biblioteket hanterar dina personuppgifter i enlighet med EU:s dataskyddsförordning (2018), GDPR. Läs mer om hur det funkar här.
Så här hanterar KB dina uppgifter vid användning av denna tjänst.

 
pil uppåt Close

Copy and save the link in order to return to this view